S. Locarnini

594 total citations
29 papers, 511 citations indexed

About

S. Locarnini is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, S. Locarnini has authored 29 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 22 papers in Hepatology and 9 papers in Infectious Diseases. Recurrent topics in S. Locarnini's work include Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (12 papers). S. Locarnini is often cited by papers focused on Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (12 papers). S. Locarnini collaborates with scholars based in Australia, China and United States. S. Locarnini's co-authors include Angeline Bartholomeusz, Peter Angus, S. Bowden, Amanda Nicoll, Scott Bowden, Thein Thein Aye, Janine McMillan, Alan Breschkin, Tim Shaw and William Sievert and has published in prestigious journals such as Hepatology, Gut and Antimicrobial Agents and Chemotherapy.

In The Last Decade

S. Locarnini

29 papers receiving 496 citations

Peers

S. Locarnini
Tuan Nguyen United States
C. Trépo France
Bandita Parhy United States
T. Santantonio Italy
Simon Siu‐Man Sum China
Watcharasak Chotiyaputta Thailand
Ana Arizcorreta Spain
Andreas Laras Greece
Floriano Rosina Italy
Catherine Barrett United Kingdom
Tuan Nguyen United States
S. Locarnini
Citations per year, relative to S. Locarnini S. Locarnini (= 1×) peers Tuan Nguyen

Countries citing papers authored by S. Locarnini

Since Specialization
Citations

This map shows the geographic impact of S. Locarnini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Locarnini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Locarnini more than expected).

Fields of papers citing papers by S. Locarnini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Locarnini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Locarnini. The network helps show where S. Locarnini may publish in the future.

Co-authorship network of co-authors of S. Locarnini

This figure shows the co-authorship network connecting the top 25 collaborators of S. Locarnini. A scholar is included among the top collaborators of S. Locarnini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Locarnini. S. Locarnini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Walsh, Renae, R. Hammond, Kathy Merlock Jackson, et al.. (2018). Effects of SB9200 (Inarigivir) therapy on immune responses in patients with chronic hepatitis B. Journal of Hepatology. 68. S89–S89. 5 indexed citations
3.
Yuen, MF, Bruce D. Given, Thomas Schluep, et al.. (2018). RNA interference therapy with ARC-520 Injection results in long term off-therapy antigen reductions in treatment naïve, HBeAg positive and negative patients with chronic HBV. Journal of Hepatology. 68. S526–S526. 7 indexed citations
4.
Podlaha, Ondřej, Peter Revill, Neeru Bhardwaj, et al.. (2017). Whole-genome deep sequencing of hepatitis B virus in chronic hepatitis B patients reveals single nucleotide variants associated with baseline HBV DNA levels and HBeAg status. Journal of Hepatology. 66(1). S679–S679. 3 indexed citations
5.
Gane, Edward, Christopher Schwabe, Bruce D. Given, et al.. (2017). A phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population. Journal of Hepatology. 66(1). S265–S265. 9 indexed citations
6.
Lok, A.S., S. Locarnini, Fabien Zoulim, et al.. (2017). Durability of HBsAg loss with nucleotide analogs and pegylated interferon in patients infected with hepatitis B virus. Journal of Hepatology. 66(1). S264–S264. 1 indexed citations
7.
Rosenberg, Gillian, Julianne Bayliss, Anuj Gaggar, et al.. (2014). P653 RECLASSIFICATION OF IMMUNOTOLERANT CHRONIC HEPATITIS B INFECTION; DETECTION OF HBV VARIANTS WITH IMPLICATIONS FOR HBV DNA, HBsAg AND HBeAg LEVELS. Journal of Hepatology. 60(1). S286–S286. 1 indexed citations
8.
Ayres, A., Lilly Yuen, S. Manoharan, et al.. (2011). 736 LAMIVUDINE IN LATE PREGNANCY FOR PREVENTION OF HBV TRANSMISSION: EFFECTIVENESS AND DETECTION OF ANTIVIRAL RESISTANCE. Journal of Hepatology. 54. S295–S296. 6 indexed citations
9.
Patterson, Scott J., Jacob George, Simone I. Strasser, et al.. (2010). Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut. 60(2). 247–254. 153 indexed citations
10.
Thompson, A., et al.. (2009). 370 SERUM HBeAg AND HBsAg CONCENTRATIONS: CHANGING LEVELS DURING THE NATURAL HISTORY OF CHRONIC HEPATITIS B. Journal of Hepatology. 50. S141–S141. 1 indexed citations
11.
Bartholomeusz, Angeline, et al.. (2007). [486] UNDERSTANDING HBV RESISTANCE TO TELBIVUDINE: MOLECULAR MODELLING AND DATABASE MINING. Journal of Hepatology. 46. S185–S185. 3 indexed citations
12.
Locarnini, S., et al.. (2007). [506] IN VITRO PHENOTYPIC TESTING AND HBV DRUG RESISTANCE: ROLE IN DIRECTING RATIONAL ONGOING ANTIVIRAL THERAPY. Journal of Hepatology. 46. S192–S193. 1 indexed citations
13.
Locarnini, S., Timothy J. Shaw, Jonathan L. E. Dean, et al.. (2004). Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. Journal of Clinical Virology. 32(2). 113–121. 21 indexed citations
14.
Xiong, S., C. Westland, William E. Delaney, et al.. (2003). Resistance surveillance of HBEAG— chronic hepatitis B (CHB) patients treated for two years with adefovir dipivoxil (ADV). Journal of Hepatology. 38. 182–182. 35 indexed citations
15.
Colledge, Danni, Timothy J. Shaw, S. Bowden, et al.. (2002). The purine nucleotide analogue LY582563 (mcc-478) inhibits replication of wild type and drug resistant hepatitis b virus. Journal of Hepatology. 36. 88–88. 3 indexed citations
16.
Bartholomeusz, Angeline & S. Locarnini. (2001). Hepatitis B Virus Mutants and Fulminant Hepatitis B: Fitness Plus Phenotype. Hepatology. 34(2). 432–435. 42 indexed citations
17.
Locarnini, S., et al.. (2001). Hepatitis B virion (HBV) clearance is extremely rapid in a sub-set of chronically infected individuals. Journal of Hepatology. 34. 124–124. 1 indexed citations
18.
Aye, Thein Thein, Angeline Bartholomeusz, Tim Shaw, et al.. (1997). Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. Journal of Hepatology. 26(5). 1148–1153. 129 indexed citations
19.
Nicoll, Amanda, Peter Angus, S. T. Chou, et al.. (1997). Demonstration of Duck Hepatitis B Virus in Bile Duct Epithelial Cells: Implications for Pathogenesis and Persistent Infection. Hepatology. 25(2). 463–469. 21 indexed citations
20.
Wang, Yingying, Carolyn A. Luscombe, S. Bowden, Timothy J. Shaw, & S. Locarnini. (1995). Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid. Antimicrobial Agents and Chemotherapy. 39(2). 556–558. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tuan Nguyen Breakdown of academic impact, for papers by C. Trépo Breakdown of academic impact, for papers by Bandita Parhy Breakdown of academic impact, for papers by T. Santantonio Breakdown of academic impact, for papers by Simon Siu‐Man Sum Breakdown of academic impact, for papers by Watcharasak Chotiyaputta Breakdown of academic impact, for papers by Ana Arizcorreta Breakdown of academic impact, for papers by Andreas Laras Breakdown of academic impact, for papers by Floriano Rosina Breakdown of academic impact, for papers by Catherine Barrett
Rankless by CCL
2026